CREDIT SUISSE AG/ - IMMUNOPRECISE ANTIBODIES LTD ownership

IMMUNOPRECISE ANTIBODIES LTD's ticker is IPA and the CUSIP is 45257F200. A total of 27 filers reported holding IMMUNOPRECISE ANTIBODIES LTD in Q4 2021. The put-call ratio across all filers is 0.56 and the average weighting 0.0%.

Quarter-by-quarter ownership
CREDIT SUISSE AG/ ownership history of IMMUNOPRECISE ANTIBODIES LTD
ValueSharesWeighting
Q4 2021$317,000
-42.7%
59,172
-33.4%
0.00%
Q3 2021$553,000
+137.3%
88,829
+130.0%
0.00%
Q2 2021$233,000
-29.0%
38,623
+15.6%
0.00%
Q1 2021$328,00033,4230.00%
Other shareholders
IMMUNOPRECISE ANTIBODIES LTD shareholders Q4 2021
NameSharesValueWeighting ↓
INGALLS & SNYDER LLC 970,147$5,0540.28%
Gradient Capital Advisors, LLC 26,808$139,6700.06%
KRAEMATON INVESTMENT ADVISORS, INC 1,600$8,3360.01%
WEST PACES ADVISORS INC. 1,665$8,6750.00%
Tower Research Capital LLC (TRC) 2,432$130.00%
BANK OF MONTREAL /CAN/ 240,980$1,247,6600.00%
CIBC WORLD MARKET INC. 47,427$2510.00%
DIMENSIONAL FUND ADVISORS LP 27,661$1460.00%
BANK OF AMERICA CORP /DE/ 2,000$10,4200.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
View complete list of IMMUNOPRECISE ANTIBODIES LTD shareholders